KRAS and cancer: In this review we will focus on the driver oncogenes and oncogenic pathways that are frequently activated in tumors of different origin, are known to cause phenotypic addiction of cancer cells, and are involved in splicing modification: mutated TP53, CMYC, KRAS, PI3K, SRSF1, and hnRNPA1.